	Long-term effects of L-carnitine on hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis: a multicenter retrospective study. Eur J Gastroenterol Hepatol Tani J, Moriya A, Tomonari T, Ogawa C, Tsutsui A, Morishita A, Sakamoto T, Tai H, Yano R, Nakahara M, Oura K, Tadokoro T, Fujita K, Mimura S, Himoto T, Tanaka H, Imado R, Manabe T, Takuma K, Nagano T, Takaguchi K, Takayama T, Kobara H. PMID: 41870958 [PubMed - as supplied by publisher]
	Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test. Technol Cancer Res Treat Chen L, Liu J, Long M, Hu P. PMID: 41869803 [PubMed - indexed for MEDLINE]
	Reassessing the Baveno based strategy in China: a cost-effectiveness analysis of screening for high-risk varices in cirrhosis. Front Public Health Su S, Luo J, Li C, Yang C, Yang J, Ding D, Liu X, Guo G, Han Y. PMID: 41869588 [PubMed - indexed for MEDLINE]
	Nanomedicine-Driven Modulation of Signaling Pathways in Hepatic Fibrosis. Int J Nanomedicine Ji P, Li Y, Jin Y, Dong Y, Li L, Ma Z, Liu L, Zhang Y, Ren Z. PMID: 41869405 [PubMed - indexed for MEDLINE]
	The Dual-Faceted Role of Metal-Based Nanomaterials in Hepatic Fibrosis Therapy. Int J Nanomedicine Mao Y, Gong Y, Bai X. PMID: 41869402 [PubMed - indexed for MEDLINE]
	Identification of potential biomarkers and therapeutic targets for liver cirrhosis based on Mendelian randomization and machine learning. Biochem Biophys Rep Zhang K, Chen T, Jia Z, Zhao J, Huang N. PMID: 41869075 [PubMed]
	Nomogram Using Taurocholic Acid, Age, and Albumin to Predict HBV-Related Cirrhosis/HCC in CHB Patients. J Hepatocell Carcinoma Zhang X, Zheng L, Zheng W, Shi J, Yu S, Liu H, Feng H, Yu Z. PMID: 41868263 [PubMed]
	HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients. J Hepatocell Carcinoma Indre MG, Stefanini B, Boe M, Capelli R, Chen R, Abbati C, Santangeli E, Salamone A, Girolami F, Tovoli F, Morelli MC, Piscaglia F, Ferri S, Ravaioli F. PMID: 41868260 [PubMed]
	Ammonia measurement in cirrhosis: International Delphi consensus recommendations from ISHEN. J Hepatol Ballester MP, Gallego-Durán R, Shalimar, Thomsen KL, Karvellas CJ, Dasarathy S, Shawcross DL, Thabut D, Chen J, Rose CF, Jalan R, Delphi panellists. PMID: 41865800 [PubMed - as supplied by publisher]
	Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial. Sci Rep Glal KAM, El-Haggar SM, Abdel-Salam SM, Mostafa TM. PMID: 41865069 [PubMed - as supplied by publisher]
	Association of nonselective Î² blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis. Ann Hepatol Xu Y, Wang X, Li X, Zhao Q, Xu X. PMID: 41864541 [PubMed - as supplied by publisher]
	Rheumatic Heart Disease Is Not Over: Cardiac Cirrhosis and Multivalvular Sequelae in an Endemic Setting - A Case Series and Review. Curr Probl Cardiol Sethi Y, Yadav ND, Singhal S, Singh AP, Singh A, Agarwal S, Sharma A, Pavlovic C, Pavlovic T, Mehta S. PMID: 41864251 [PubMed - as supplied by publisher]
	Analysis of 6-week mortality and influencing factors in patients with liver cirrhosis and portal vein thrombosis complicated by acute gastrointestinal bleeding. PLoS One Zhang J, Feng L. PMID: 41860832 [PubMed - indexed for MEDLINE]
	Focal lesions in the cirrhotic liver: an update on LI-RADS classification and clinical implications. Dig Liver Dis Blandino AA, Vernuccio F, Cannella R, Kilcoyne A, Tsai LL, Brancatelli G. PMID: 41856903 [PubMed - as supplied by publisher]
	Disentangling the Effect of BMI on Hepatocellular Carcinoma From Cirrhosis With Multivariable Mendelian Randomization. Liver Int Gkatzionis A, Sanderson E, Smith GD, Stender S, Gellert-Kristensen H. PMID: 41853930 [PubMed - indexed for MEDLINE]
	Continuous Versus Bolus Terlipressin for Acute Oesophageal Variceal Bleeding and Hepatorenal Syndrome in Cirrhosis: Meta-Analysis. Liver Int Hsieh PH, Yang TC, Kang EY, Chen YF, Lee PC, Lee KC, Huang HC, Luo JC, Hou MC. PMID: 41853888 [PubMed - indexed for MEDLINE]
	Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review. Liver Int van Eekhout KMA, Broekman LD, de Jong VD, Michel M, Grobbee R, Maya-Miles D, Romero-Gómez M, Muris J, Mendive JM, Vali Y, Franco OH, Schattenberg JM, Fournier-Poizat C, Castro Cabezas M, Tushuizen ME, Holleboom AG. PMID: 41852336 [PubMed - indexed for MEDLINE]
	Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis. Liver Int Pompili E, Iannone G, Piano S, Toniutto P, Lombardo A, Gioia S, Tonon M, Gagliardi R, Carrello D, Tedesco G, Di Marco V, Zaccherini G, Lani L, Baldassarre M, Nardelli S, Bitetto D, Calvaruso V, Angeli P, Caraceni P. PMID: 41851602 [PubMed - indexed for MEDLINE]
	Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria. Clin Radiol Gong W, Gong S, Chang H, Ma C, Zhao Q, Zhou X, Zhou H. PMID: 41849926 [PubMed - as supplied by publisher]
	Clinical management of portal vein thrombosis in cirrhosis: an evidenceâ€‘based narrative review. CVIR Endovasc Dai K, Hansi N, See TC. PMID: 41848981 [PubMed]

Articles 1 - 20 / 38195

Page 1 of 1910



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy